Skip to main content
. 2025 Jul 7;15(7):292. doi: 10.3390/jpm15070292
PAD Peripheral artery disease
CLTI Chronic limb-threatening ischemia
VKAs Vitamin K antagonists
CVD Cardiovascular disease
MACEs Major adverse cardiovascular events
DAPT Dual antiplatelet therapy
MALEs Major adverse limb events
SFA Superficial femoral artery
DOACs Direct oral anticoagulants
CAD Coronary artery disease
HBR High bleeding risk
SD Standard deviation
CIs Confidence intervals